FDA faces call from inside agency to halt approval of new opioids
The Guardian -

Specialists with the FDA says agency’s ‘dangerously deficient oversight’ is continuing to fuel the opioid epidemic

The US Food and Drug Administration is facing a demand from some of its own specialists to halt the approval of new narcotic painkillers because they say the agency’s “dangerously deficient oversight” is continuing to fuel the opioid epidemic.

Dr Sidney Wolfe, a former member of the FDA’s drug safety committee, and Dr Raeford Brown, the present chair of the agency’s opioid advisory...

Read this story at


Related Articles